pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Tecentriq · news · pharmadog
← back to Tecentriq
News mentioning Tecentriq
18
stories
7d
BioNTech faces 3rd mRNA setback as head and neck cancer therapy fails to improve survival
biospace
11d
City Therapeutics targets $158M IPO; Iambic seeks $135M Nasdaq debut
endpoints
13d
Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial
biopharma dive
Sep 14, 26
Roche, MediLink notch phase 3 lung cancer win but trail GSK on cross-trial survival
fiercebiotech
Sep 14, 26
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
biospace
Sep 11, 26
FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer
fiercebiotech
Sep 11, 26
BioNTech sets survival standard in hard-to-treat cancer ahead of pivotal readout
fiercebiotech
Sep 10, 26
The signal that changes everything: understanding MRD in oncology drug development
fiercebiotech
Sep 8, 26
FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer
fiercebiotech
Aug 28, 26
BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer
biospace
Aug 26, 26
Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate
fiercebiotech
Jul 27, 26
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
biospace
Jul 23, 26
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
fiercebiotech
May 18, 26
Design Therapeutics' Friedreich's ataxia data; Vincentage's obesity results from China
endpoints
May 15, 26
Dr Hafron on the FDA Approval of Adjuvant Atezolizumab in MRD+ MIBC
onclive
May 15, 26
FDA Approves Adjuvant Atezolizumab for MRD+ Muscle-Invasive Bladder Cancer
onclive
May 7, 26
Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026
onclive
May 5, 26
Simlukafusp Alfa Regimens Show Manageable Safety and Activity But Do Not Outperform SOC in Metastatic RCC
onclive
